Windtree Therapeutics Inc /De/ financial data

Symbol
WINT on Nasdaq, WINTW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
2600 Kelly Road, Suite 100, Warrington, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
DISCOVERY LABORATORIES INC /DE/ (to 4/18/2016), ANSAN PHARMACEUTICALS INC (to 7/21/1997), ANSAN INC (to 5/15/1996)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.7 % -66.9%
Debt-to-equity 304 % +20.9%
Return On Equity -153 % +28%
Return On Assets -35.8 % +40.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 592K shares -88.5%
Common Stock, Shares, Outstanding 592K shares -88.5%
Entity Public Float 6.2M USD -32.6%
Common Stock, Value, Issued 1K USD -80%
Weighted Average Number of Shares Outstanding, Basic 575K shares +157%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 17.3M USD +191%
Operating Income (Loss) -25.5M USD +3.42%
Nonoperating Income (Expense) 14.4M USD +2376%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.8M USD -79.2%
Income Tax Expense (Benefit) 197K USD
Net Income (Loss) Attributable to Parent -11.4M USD +53.5%
Earnings Per Share, Basic 111 USD/shares +29%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.8M USD -84.3%
Assets, Current 2.06M USD -84.5%
Property, Plant and Equipment, Net 150K USD -30.6%
Operating Lease, Right-of-Use Asset 1.24M USD -24.5%
Intangible Assets, Net (Excluding Goodwill) 9.7M USD -42.9%
Goodwill 0 USD
Assets 28.7M USD -29.3%
Accounts Payable, Current 2.97M USD +208%
Employee-related Liabilities, Current 64K USD -48%
Accrued Liabilities, Current 2.13M USD +22.9%
Liabilities, Current 8.78M USD +131%
Deferred Income Tax Liabilities, Net 4.77M USD -4.18%
Operating Lease, Liability, Noncurrent 912K USD -34.7%
Other Liabilities, Noncurrent 3.8M USD 0%
Liabilities 18.3M USD -37%
Retained Earnings (Accumulated Deficit) -847M USD -1.36%
Stockholders' Equity Attributable to Parent 3.49M USD -69.9%
Liabilities and Equity 28.7M USD -29.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.95M USD -17%
Net Cash Provided by (Used in) Financing Activities 1.03M USD +75%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 592K shares -88.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.91M USD +0.78%
Deferred Tax Assets, Valuation Allowance 185M USD -12.3%
Deferred Tax Assets, Gross 185M USD -12.3%
Operating Lease, Liability 1.6M USD -21.3%
Depreciation 21K USD -8.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.78M USD -23.9%
Property, Plant and Equipment, Gross 3.92M USD +0.1%
Operating Lease, Liability, Current 457K USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 570K USD +1.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 531K USD +0.38%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 182K USD -41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 581K USD +1.93%
Deferred Tax Assets, Operating Loss Carryforwards 159M USD -14.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.99M shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 97K USD -83.3%
Additional Paid in Capital 853M USD +0.39%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 959K USD -56.4%
Interest Expense 51K USD -1.92%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%